Search for: "Astrazeneca LP"
Results 61 - 80
of 155
Sorted by Relevance
|
Sort by Date
15 Apr 2016, 8:26 am
These medications are available by prescription and over-the-counter (OTC) from various pharmaceutical companies, for example: PRILOSEC (omeprazole magnesium) | prescription drug | AstraZeneca LPPRILOSEC OTC (omeprazole magnesium) | over-the-counter | Procter & Gamble Manufacturing Co.PREVACID (lansoprazole) | prescription drug | Takeda Pharmaceuticals America, Inc.PREVACID 24 HR (lansoprazole) | over-the-counter | Novartis Consumer Health, Inc.NEXIUM (esomeprazole magnesium) |… [read post]
19 Oct 2023, 4:00 am
AstraZeneca Pharmaceuticals LP, (D MD, Oct. 17, 2023), a Maryland federal district court dismissed a Title VII religious discrimination claim by two employees who were denied a religious exemption from a company's Covid vaccine mandate, finding that their objections were not religious in nature. [read post]
25 May 2009, 4:56 am
AstraZeneca LP, 605 F.Supp.2d 669, 2009 WL 827920, *1 (W.D.Pa. 2009). [read post]
30 Nov 2012, 7:45 am
No. 10-915-LPS (D. [read post]
29 Aug 2016, 12:30 pm
For use as an example, here is the relevant part of an August 17, 2016 FDA Supplemental Approval letter to AstraZeneca Pharmaceuticals LP for Farxiga: Please refer to your supplemental New Drug Application (sNDA) dated and received July 28 2016, submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act (FDCA) for Farxiga (dapagliflozin) tablets. [read post]
27 Feb 2015, 5:02 am
AstraZeneca to Pay $7.9 Million to Resolve Kickback Allegations AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act. [read post]
20 Apr 2012, 10:36 am
McGrath In its recent decision in AstraZeneca Pharmaceuticals LP v. [read post]
27 May 2009, 12:44 am
"AstraZeneca LP v. [read post]
3 Oct 2010, 8:57 pm
Astrazeneca Pharmaceuticals LP... [read post]
26 Mar 2012, 1:43 am
District Court for the District of Columbia denied AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) Application for Prelimiary Injunction and dismissed without prejudice the action AstraZeneca filed on March 12, 2012 seeking to enjoing FDA from granting final ANDA approval for a generic version of the company’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets (NDA No. 020639) as early as March 26, 2012 (as well… [read post]
29 Nov 2012, 5:21 am
No. 10-915-LPS (D. [read post]
23 Sep 2009, 10:02 pm
AstraZeneca Pharmaceuticals LP, No. 08-1056 (1st Cir. [read post]
25 May 2012, 11:32 am
Judge Stark cited the Federal Circuit’s recent decision in AstraZeneca Pharmaceuticals LP v. [read post]
9 Jul 2012, 7:41 pm
Karst – In a decision that, unless appealed, marks the end of AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) battle with FDA over the approval of generic versions of the company’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets, the U.S. [read post]
9 Jan 2012, 10:13 am
AstraZeneca Pharmaceuticals LP, 2-11-cv-00807 (SCD January 4, 2012, Order) (Austin, M.J.) [read post]
3 Nov 2010, 5:56 am
Astrazeneca Pharmaceuticals LP, et. al., 2-08-cv-04786 (PAED October 20, 2010, Memorandum and/or Opinion) (Yohn, J.) [read post]
26 Nov 2008, 7:57 am
"AstraZeneca Pharmaceuticals LP v. [read post]
23 May 2016, 7:49 am
The Court reasoned that (1) like the generic in AstraZeneca Pharmaceuticals LP v. [read post]
17 Feb 2010, 8:00 am
Aquatron Inc. and Aqua Group LLC (patent infringement) 1/7: AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited and AstraZeneca AB v. [read post]
